Multiple Nucleotide Preferences Determine Cleavage-Site Recognition by the HIV-1 and M-MuLV RNases H

Journal of Molecular Biology

Volumn 397, Issue 1, 2010, Pages 161-178

  Schultz, Sharon J ^a   Zhang, Miaohua ^a   Champoux, James J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

human immunodeficiency virus type 1, HIV 1; Moloney murine leukemia virus, M MuLV; reverse transcriptase; reverse transcription; RNase H

Indexed keywords

RNA HELICASE;

ARTICLE; ENZYME SPECIFICITY; GENE CLUSTER; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; OPERON; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; RNA CLEAVAGE; VIRUS ISOLATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS;

EID: 77249127853     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.01.059     Document Type: Article

References (49)

1. Arts E.J., and LeGrice S.F.J. Interaction of retroviral reverse transcriptase with template-primer duplexes during replication. Prog. Nucleic Acid Res. Mol. Biol. 58 (1998) 339-393
2. Telesnitsky A., and Goff S.P. Strong-stop strand transfer during reverse transcription. In: Skalka A.M., and Goff S.P. (Eds). Reverse Transcriptase (1993), Cold Spring Harbor Laboratory Press, Plainview, NY 49-83
3. Tisdale M., Schulze T., Larder B.A., and Moelling K. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J. Gen. Virol. 72 (1991) 59-66
4. Tanese N., Telesnitsky A., and Goff S.P. Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function. J. Virol. 65 (1991) 4387-4397
5. Repaske R., Hartley J.W., Kavlick M.F., O'Neill R.R., and Austin J.B. Inhibition of RNase H activity and viral replication by single mutations in the 3′ region of Moloney murine leukemia virus reverse transcriptase. J. Virol. 63 (1989) 1460-1464
6. Nikolenko G.N., Svarovskaia E.S., Delviks K.A., and Pathak V.K. Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency. J. Virol. 78 (2004) 8761-8770
7. di Marzo Veronese F., Copeland T.D., DeVico A.L., Rahman R., Oroszlan S., Gallo R.C., and Sarngadharan M.G. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231 (1986) 1289-1291
8. Telesnitsky A., and Goff S.P. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template. Proc. Natl Acad. Sci. USA 90 (1993) 1276-1280
9. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., and Steitz T.A. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256 (1992) 1783-1790
10. Ding J., Das K., Hsiou Y., Sarafianos S.G., Clark Jr. A.D., Jacobo-Molina A., et al. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 Å resolution. J. Mol. Biol. 284 (1998) 1095-1111
11. Huang H., Chopra R., Verdine G.L., and Harrison S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282 (1998) 1669-1675
12. Sarafianos S.G., Das K., Tantillo C., Clark Jr. A.D., Ding J., Whitcomb J.M., et al. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20 (2001) 1449-1461
13. Das D., and Georgiadis M.M. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure (Camb.) 12 (2004) 819-829
14. Jacobo-Molina A., Ding J., Nanni R.G., Clark Jr. A.D., Lu X., Tantillo C., et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl Acad. Sci. USA 90 (1993) 6320-6324
15. Champoux J.J., and Schultz S.J. Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription. FEBS J. 276 (2009) 1506-1516
16. Champoux J.J. Roles of ribonuclease H in reverse transcription. In: Skalka A.M., and Goff S.P. (Eds). Reverse Transcriptase (1993), Cold Spring Harbor Press, Cold Spring Harbor, NY 103-118
17. Klumpp K., and Mirzadegan T. Recent progress in the design of small molecule inhibitors of HIV RNase H. Curr. Pharm. Des. 12 (2006) 1909-1922
18. Schultz S.J., and Champoux J.J. RNase H activity: structure, specificity, and function in reverse transcription. Virus Res. 134 (2008) 86-103
19. Fuentes G.M., Rodriguez-Rodriguez L., Fay P.J., and Bambara R.A. Use of an oligoribonucleotide containing the polypurine tract sequence as a primer by HIV reverse transcriptase. J. Biol. Chem. 270 (1995) 28169-28176
20. Kelleher C.D., and Champoux J.J. RNA degradation and primer selection by Moloney murine leukemia virus reverse transcriptase contribute to the accuracy of plus strand initiation. J. Biol. Chem. 275 (2000) 13061-13070
21. Schultz S.J., Zhang M., Kelleher C.D., and Champoux J.J. Analysis of plus-strand primer selection, removal, and reutilization by retroviral reverse transcriptases. J. Biol. Chem. 275 (2000) 32299-32309
22. Schultz S.J., Zhang M., and Champoux J.J. Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus. J. Virol. 77 (2003) 5275-5285
23. Schultz S.J., Zhang M., and Champoux J.J. Recognition of internal cleavage sites by retroviral RNases H. J. Mol. Biol. 344 (2004) 635-652
24. DeStefano J.J., Cristofaro J.V., Derebail S., Bohlayer W.P., and Fitzgerald-Heath M.J. Physical mapping of HIV reverse transcriptase to the 5′ end of RNA primers. J. Biol. Chem. 276 (2001) 32515-32521
25. DeStefano J.J., Bambara R.A., and Fay P.J. Parameters that influence the binding of human immunodeficiency virus reverse transcriptase to nucleic acid structures. Biochemistry 32 (1993) 6908-6915
26. DeStefano J.J., Mallaber L.M., Fay P.J., and Bambara R.A. Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase. Nucleic Acids Res. 21 (1993) 4330-4338
27. Palaniappan C., Fuentes G.M., Rodriguez-Rodriguez L., Fay P.J., and Bambara R.A. Helix structure and ends of RNA/DNA hybrids direct the cleavage specificity of HIV-1 reverse transcriptase RNase H. J. Biol. Chem. 271 (1996) 2063-2070
28. Schultz S.J., Zhang M., and Champoux J.J. Preferred sequences within a defined cleavage window specify DNA 3′ end-directed cleavages by retroviral RNases H. J. Biol. Chem. 284 (2009) 32225-32238
29. Schultz S.J., Zhang M., and Champoux J.J. Sequence, distance, and accessibility are determinants of 5′-end-directed cleavages by retroviral RNases H. J. Biol. Chem. 281 (2006) 1943-1955
30. Schultz S.J., and Champoux J.J. RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity. J. Virol. 70 (1996) 8630-8638
31. Zhan X., and Crouch R.J. The isolated RNase H domain of murine leukemia virus reverse transcriptase. Retention of activity with concomitant loss of specificity. J. Biol. Chem. 272 (1997) 22023-22029
32. Shinnick T.M., Lerner R.A., and Sutcliffe J.G. Nucleotide sequence of Moloney murine leukaemia virus. Nature 293 (1981) 543-548
33. DeStefano J.J. The orientation of binding of human immunodeficiency virus reverse transcriptase on nucleic acid hybrids. Nucleic Acids Res. 23 (1995) 3901-3908
34. Furfine E.S., and Reardon J.E. Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J. Biol. Chem. 266 (1991) 406-412
35. Gopalakrishnan V., Peliska J.A., and Benkovic S.J. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc. Natl Acad. Sci. USA 89 (1992) 10763-10767
36. Kati W.M., Johnson K.A., Jerva L.F., and Anderson K.S. Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 267 (1992) 25988-25997
37. Lim D., Gregorio G.G., Bingman C., Martinez-Hackert E., Hendrickson W.A., and Goff S.P. Crystal structure of the Moloney murine leukemia virus RNase H domain. J. Virol. 80 (2006) 8379-8389
38. Julias J.G., McWilliams M.J., Sarafianos S.G., Arnold E., and Hughes S.H. Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo. Proc. Natl Acad. Sci. USA 99 (2002) 9515-9520
39. Julias J.G., McWilliams M.J., Sarafianos S.G., Alvord W.G., Arnold E., and Hughes S.H. Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity. J. Virol. 77 (2003) 8548-8554
40. Rausch J.W., Lener D., Miller J.T., Julias J.G., Hughes S.H., and Le Grice S.F. Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity. Biochemistry 41 (2002) 4856-4865
41. McWilliams M.J., Julias J.G., Sarafianos S.G., Alvord W.G., Arnold E., and Hughes S.H. Mutations in the 5′ end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer. J. Virol. 77 (2003) 11150-11157
42. McWilliams M.J., Julias J.G., Sarafianos S.G., Alvord W.G., Arnold E., and Hughes S.H. Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization. Virology 348 (2006) 378-388
43. Hostomsky Z., Hostomska Z., Hudson G.O., Moomaw E.W., and Nodes B.R. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 88 (1991) 1148-1152
44. Smith J.S., and Roth M.J. Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain. J. Virol. 67 (1993) 4037-4049
45. Tanese N., and Goff S.P. Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proc. Natl Acad. Sci. USA 85 (1988) 1777-1781
46. Tadokoro T., and Kanaya S. Ribonuclease H: molecular diversities, substrate binding domains, and catalytic mechanism of the prokaryotic enzymes. FEBS J. 276 (2009) 1482-1493
47. Cerritelli S.M., and Crouch R.J. Ribonuclease H: the enzymes in eukaryotes. FEBS J. 276 (2009) 1494-1505
48. Nowotny M., Gaidamakov S.A., Ghirlando R., Cerritelli S.M., Crouch R.J., and Yang W. Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription. Mol. Cell 28 (2007) 264-276
49. Han G.W., Kopka M.L., Cascio D., Grzeskowiak K., and Dickerson R.E. Structure of a DNA analog of the primer for HIV-1 RT second strand synthesis. J. Mol. Biol. 269 (1997) 811-826